Renal cancer: molecular mechanisms and newer therapeutic options
- 1 January 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Nephrology and Hypertension
- Vol. 11 (1), 37-42
- https://doi.org/10.1097/00041552-200201000-00006
Abstract
Renal cell carcinomas account for 80-85% of all primary renal neoplasms. Recent identification of VHL, c-met and TSC as candidate genes mutated in various types of renal carcinomas has greatly enhanced our understanding of the pathogenesis of renal carcinomas and has provided novel therapeutic options for patients with renal cancer. Furthermore, developments in angiogenesis and in tumor immunology have given us additional treatment modalities for cancer patients, especially those with renal cancer. This review highlights the genetic abnormalities seen in renal cell carcinomas and reviews current and future therapeutic options.Keywords
This publication has 36 references indexed in Scilit:
- VHL tumor suppressor regulates Cl−/HCO3−exchange and Na+/H+exchange activities in renal carcinoma cellsPhysiological Genomics, 2001
- Vascular tumors in livers with targeted inactivation of the von Hippel–Lindau tumor suppressorProceedings of the National Academy of Sciences, 2001
- Role of transforming growth factor-alpha in von Hippel- Lindau (VHL)-/- clear cell renal carcinoma cell proliferation: A possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesisProceedings of the National Academy of Sciences, 2001
- Identification of the von Hippel–Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complexProceedings of the National Academy of Sciences, 1999
- Advances in the molecular basis of renal neoplasiaCurrent Opinion in Nephrology and Hypertension, 1999
- The von Hippel-Lindau Tumor Suppressor Gene Product Interacts with Sp1 To Repress Vascular Endothelial Growth Factor Promoter ActivityMolecular and Cellular Biology, 1997
- Defective placental vasculogenesis causes embryonic lethality in VHL-deficient miceProceedings of the National Academy of Sciences, 1997
- Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.Proceedings of the National Academy of Sciences, 1996
- Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene.Proceedings of the National Academy of Sciences, 1996
- Mutations of the VHL tumour suppressor gene in renal carcinomaNature Genetics, 1994